Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | Spectroscopic techniques for non-invasive diagnosis of Alzheimer’s disease

Mary Paraskevaidi • 27 Apr 2020
ARUK 2020
Alzheimer’s Disease Dementia

Mary Paraskevaidi, PhD, University of Central Lancashire, Lancashire, UK, and Imperial College London, London, UK, discusses the ability of blood-based spectroscopic technologies to differentiate normal controls from patients with Alzheimer’s disease according to their characteristic spectral information. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Mary Paraskevaidi

4:00
Benefits of early detection in Alzheimer's disease
Mary Paraskevaidi • 27 Apr 2020
2:00
The role of blood spectroscopy in the Alzheimer's disease diagnostic process
Mary Paraskevaidi • 27 Apr 2020
2:05
Alzheimer’s disease diagnosis: blood spectroscopy in the clinical setting
Mary Paraskevaidi • 27 Apr 2020
1:44
Alzheimer's disease outlook: sensitive diagnostic approaches & efficient treatments
Mary Paraskevaidi • 27 Apr 2020

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals